ProCE Banner Activity

Latest Data on CELMoDs in NHL From the Annual Hematology Meeting 

Clinical Thought

Read my commentary on the potential role of CELMoDs in patients with non-Hodgkin lymphoma (NHL) including the latest available data on CELMoDs in NHL presented at the 2024 Annual Hematology Meeting.

Released: February 28, 2025

Expiration: February 27, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Disclosure

Primary Author

Nathan Denlinger, DO, MS

Assistant Professor of Internal Medicine
BMT and Cell Therapy
Division of Hematology
Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Nathan Denlinger, DO, MS: consultant/advisor/speaker: Bristol Myers Squibb, Miltenyi Biotech.